COX/mPGES-1/PGE2pathway depicts an inflammatory-dependent high-risk neuroblastoma subset

The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance

(2014) Gvantsa Kharaishvili et al.   Cancer Cell International

Elevated expression of prostaglandin E2 synthetic pathway in skeletal muscle of prior polio patients

(2014) E Melin et al.   JOURNAL OF REHABILITATION MEDICINE

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance

(2014) Antonina V. Kurtova et al.   NATURE

Mechanisms of neuroblastoma regression

(2014) Garrett M. Brodeur et al.   Nature Reviews Clinical Oncology

Prognostic relevance of cancer-associated fibroblasts in human cancer

(2014) Janna Paulsson et al.   SEMINARS IN CANCER BIOLOGY

Functional subsets of mesenchymal cell types in the tumor microenvironment

(2014) Eliane Cortez et al.   SEMINARS IN CANCER BIOLOGY

Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma

(2013) Lena-Maria Carlson et al.   CARCINOGENESIS

Polyphenol E Enhances the Antitumor Immune Response in Neuroblastoma by Inactivating Myeloid Suppressor Cells

(2013) G. Santilli et al.   CLINICAL CANCER RESEARCH

Effects of mPGES-1 deletion on eicosanoid and fatty acid profiles in mice

(2013) Helena Idborg et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Immunosuppressive Microenvironment in Neuroblastoma

(2013) Vito Pistoia et al.   Frontiers in Oncology

PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells

(2012) Nataša Obermajer et al.   IMMUNOLOGICAL INVESTIGATIONS

Cancer-associated fibroblasts as targets for immunotherapy

(2012) Sunitha Kakarla et al.   Immunotherapy

Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma

(2012) Shahab Asgharzadeh et al.   JOURNAL OF CLINICAL ONCOLOGY

Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2

(2012) Sonia Alcolea et al.   JOURNAL OF LIPID RESEARCH

Autocrine Prostaglandin E2 Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma

(2012) Agnes Rasmuson et al.   PLoS One

Cancer-Stimulated Mesenchymal Stem Cells Create a Carcinoma Stem Cell Niche via Prostaglandin E 2 Signaling

(2012) Hua-Jung Li et al.   Cancer Discovery

Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors

(2011) Hanna Kryh et al.   BMC GENOMICS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Regulation of Immune Responses by Prostaglandin E2

(2011) P. Kalinski   JOURNAL OF IMMUNOLOGY

EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity

(2011) S Donnini et al.   ONCOGENE

Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis

(2011) Y Sasaki et al.   ONCOGENE

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner

(2010) Neta Erez et al.   CANCER CELL

Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study

(2010) Ruth Ladenstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recent Advances in Neuroblastoma

(2010) John M. Maris   NEW ENGLAND JOURNAL OF MEDICINE

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset

(2010) H. Caren et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

COX-2 Limits Prostanoid Production in Activated HUVECs and Is a Source of PGH 2 for Transcellular Metabolism to PGE 2 by Tumor Cells

(2009) M. Dolores Salvado et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors

(2009) Rana Zeine et al.   MODERN PATHOLOGY

Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells

(2009) H. Hanaka et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer

(2008) S. Jain et al.   CANCER RESEARCH

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

(2008) Susan L. Cohn et al.   JOURNAL OF CLINICAL ONCOLOGY

High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial

(2008) Andrew DJ Pearson et al.   LANCET ONCOLOGY

Tumor-growth–promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets

(2008) Ninib Baryawno et al.   NEURO-ONCOLOGY